Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway; The auxin influx carrier LAX3 promotes lateral root emergence; Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance; High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy; An evolutionarily conserved mechanism delimiting SHR movement defines a single layer of endodermis in plants; Toward minimal residual disease-directed therapy in melanoma; Receptor-Like Kinase ACR4 Restricts Formative Cell Divisions in the Arabidopsis Root; Whole-Genome Analysis of the SHORT-ROOT Developmental Pathway in       Arabidopsis; CyTOF workflow: differential discovery in high-throughput high-dimensional cytometry datasets; The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors; Bimodular auxin response controls organogenesis in Arabidopsis; Inhibiting drivers of non-mutational drug tolerance is a salvage strategy for targeted melanoma therapy; Germinal centers determine the prognostic relevance of tertiary lymphoid structures and are impaired by corticosteroids in lung squamous cell carcinoma; Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets; Predictors of responses to immune checkpoint blockade in advanced melanoma; IL-4 abrogates TH17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells; Identification of bacteria-derived HLA-bound peptides in melanoma; Hypoxia contributes to melanoma heterogeneity by triggering HIF1α-dependent phenotype switching; The mitogen-activated protein kinase pathway in melanoma part I–activation and primary resistance mechanisms to BRAF inhibition; Evaluation of clinicopathological factors in PD-1 response: derivation and validation of a prediction scale for response to PD-1 monotherapy
